FDA gets social; Baxter sells off kidney unit;

@FierceMedDev: TrovaGene recruits US Oncology Research for a pancreatic cancer Dx trial. News | Follow @FierceMedDev

@MichaelGFierce: Gene delivery method 'hijacks' tumor blood vessels. More | Follow @MichaelGFierce

> The FDA is looking to peer in on social media chatter to see if its many directives and recommendations are being heard. Article

> Baxter ($BAX) has completed the divestiture of its continuous renal replacement therapy business, selling the unit to Nikkiso Medical in order to clear its $4 billion acquisition of former rival Gambro. More

> Boston Scientific ($BSX) has appointed Yale University veteran Craig Thompson to serve as the chief medical officer of its interventional cardiology business. News

Biotech News

@FierceBiotech: FierceBiotech's first special report of 2014: An ominous trend resurfaces as new drug approvals plunge in 2013. Report | Follow @FierceBiotech

@JohnCFierce: GE beefs up life sciences division with $1.06B Thermo Fisher deal. Story | Follow @JohnCFierce

@DamianFierce: "Moon Shots" = excellent naming. MD Anderson teams up with Pfizer to advance cancer immunotherapy. Release | Follow @DamianFierce

@EmilyMFierce: 6 U.S. institutions receive $540M in cancer research funds. Item | Follow @EmilyMFierce

> J&J gambles $12.5M in rare Big Pharma bet on a stem cell therapy. More

> Fast-growing Aratana beefs up pet drug pipeline with a $44M buyout. Piece

> Analysts score the winners in the FDA's new 'breakthrough' category. News

Pharma News

@FiercePharma: Rebel Teva shareholder throws his support to presumptive CEO Vigodman. Story | Follow @FiercePharma

@EricPFierce: There were fewer NDA's approved by the FDA in 2013, but there were some significant ones. Report | Follow @EricPFierce

@CarlyHFierce: Bayer's hot-selling Eylea runs into a roadblock in its home market. More | Follow @CarlyHFierce

> Rebel Teva shareholder throws his support to presumptive CEO Vigodman. News

> Celgene, Boston Children's play tug-of-war over Revlimid royalties. Article

> Is the audience listening? FDA wants to spy on social media to find out. More

CRO News

> Cyprotex bags a U.S. CRO for up to $5.1M. Report

> DaVita ups its CRO weight with latest partnership. News

> Sanofi stops short of baring it all with clinical trial transparency pledge. More

> Can Parexel regain some confidence after a major slip? Article

> India further tightens clinical trial rules as demand plummets. Story

> Report: Big or small, CROs need good relationships to thrive. Item

Biotech IT News

> Google VC commits to $15M round to advance DNAnexus' data hub ambitions. Report

> NIH puts improved data handling at top of BRAIN Initiative wish list. Story

> FDA plans raft of IT guidance documents to further GDUFA goals. News

> Days after Big Pharma trumpets data sharing plans, U.K. politicians push for more transparency. Article

> Spun out of George Church's lab, Curoverse gets $1.5M for open-source bio Big Data. More

> IMS Health files for IPO after making string of tech takeovers. Item

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.